irasia.com - Investor Relations Asia Pacific
HOME

CSPC Pharmaceutical Group Limited
(Formerly known as China Pharmaceutical Group Limited)
(Incorporated in Hong Kong under the Companies Ordinance)

Announcements & Notices       


Please download the latest "Acrobat Reader" to view the PDF.

  • 2019-December-30
  • VOLUNTARY ANNOUNCEMENT - TERMINATION OF PRODUCT CO-DEVELOPMENT AND STRATEGIC COLLABORATION AGREEMENT (in PDF)
  • 2019-December-30
  • VOLUNTARY ANNOUNCEMENT - THE GROUP'S "PREGABALIN CAPSULES" WAS GRANTED THE U.S. ANDA APPROVAL (in PDF)
  • 2019-December-20
  • VOLUNTARY ANNOUNCEMENT - NEW DRUG APPROVAL OF THE GROUP'S "LEVOAMLODIPINE MALEATE TABLETS" GRANTED BY THE U.S. FDA (in PDF)
  • 2019-December-11
  • VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR THE GROUP'S "IBUPROFEN TABLETS" (in PDF)
  • 2019-December-9
  • REVISION OF ANNUAL CAPS FOR EXISTING CONTINUING CONNECTED TRANSACTIONS (in PDF)
  • 2019-November-27
  • VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR THE GROUP'S "CEFIXIME CAPSULES" (in PDF)
  • 2019-November-27
  • VOLUNTARY ANNOUNCEMENT - SUBMISSION OF CLINICAL TRIAL APPLICATION FOR INVESTIGATIONAL FIRST-IN-CLASS NEW DRUG ALMB-0168 IN AUSTRALIA (in PDF)
  • 2019-November-18
  • QUARTERLY RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2019 (in PDF)
  • 2019-November-7
  • VOLUNTARY ANNOUNCEMENT - PRODUCT TRANSFER AGREEMENT (in PDF)
  • 2019-November-6
  • DATE OF BOARD MEETING (in PDF)
  • 2019-November-1
  • VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR THE GROUP'S "CEPHALEXIN CAPSULES" (in PDF)
  • 2019-November-1
  • VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR THE GROUP'S "CLINDAMYCIN HYDROCHLORIDE CAPSULES" (in PDF)
  • 2019-November-1
  • VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR THE GROUP'S "ENALAPRIL MALEATE TABLETS" (in PDF)
  • 2019-October-31
  • VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR THE GROUP'S "IBUPROFEN GRANULES" (in PDF)
  • 2019-October-31
  • VOLUNTARY ANNOUNCEMENT - "RECOMBINANT ANTI-EpCAM AND ANTI-CD3 HUMAN-MOUSE CHIMERIC BISPECIFIC ANTIBODY FOR INJECTION" WAS GRANTED CLINICAL TRIAL APPROVAL BY U.S. FDA (in PDF)
  • 2019-October-29
  • VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "DRONEDARONE HYDROCHLORIDE TABLET" (in PDF)
  • 2019-October-27
  • INSIDE INFORMATION - PRINCIPAL ACCOUNTING DATA AND FINANCIAL INDICATORS OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2019 (in PDF)
  • 2019-October-22
  • VOLUNTARY ANNOUNCEMENT - ANTI-TUMOR NANODRUG "EPIRUBICIN HYDROCHLORIDE LIPOSOME INJECTION" WAS GRANTED CLINICAL TRIAL APPROVAL (in PDF)
  • 2019-October-21
  • VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL NEW DRUG ALMB-0166 WAS GRANTED CLINICAL TRIAL APPROVAL IN AUSTRALIA (in PDF)
  • 2019-October-18
  • VOLUNTARY ANNOUNCEMENT - FIRST-IN-CLASS PRODUCT CANDIDATE ALMB-0168 GRANTED RARE PEDIATRIC DISEASE DESIGNATION BY THE U.S. FDA (in PDF)
  • 2019-October-14
  • INSIDE INFORMATION - ANNOUNCEMENT ON THE INDICATIVE RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2019 OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. (in PDF)
  • 2019-September-26
  • VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "GLUTATHIONE FOR INJECTION" (in PDF)
  • 2019-September-26
  • VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS" (in PDF)
  • 2019-September-23
  • FIRST-IN-CLASS PRODUCT CANDIDATE ALMB-0168 WAS GRANTED ORPHAN-DRUG DESIGNATION BY THE U.S. FDA (in PDF)
  • 2019-September-10
  • VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR THE GROUP'S "CEFUROXIME AXETIL TABLETS" (in PDF)
  • 2019-September-2
  • VOLUNTARY ANNOUNCEMENT - RECOMBINANT ANTI-HER2 AND ANTI-CD3 HUMANIZED BISPECIFIC ANTIBODY FOR INJECTION WAS GRANTED CLINICAL TRIAL APPROVAL BY U.S. FDA (in PDF)
  • 2019-August-21
  • VOLUNTARY ANNOUNCEMENT - NEW TARGET ANTI-TUMOR DRUG "SYHA1801" WAS GRANTED CLINICAL TRIAL APPROVAL (in PDF)
  • 2019-August-19
  • VOLUNTARY ANNOUNCEMENT - PRODUCT LICENSING AND COMMERCIALIZATION AGREEMENT (in PDF)
  • 2019-August-19
  • 2019 INTERIM RESULTS ANNOUNCEMENT (in PDF)
  • 2019-August-18
  • INSIDE INFORMATION - PRINCIPAL ACCOUNTING DATA AND FINANCIAL INDICATORS OF CSPC INNOVATION PHARMACEUTICAL CO., LTD.* FOR THE HALF YEAR ENDED 30 JUNE 2019 (in PDF)
  • 2019-August-15
  • VOLUNTARY ANNOUNCEMENT - SUBMISSION OF CLINICAL TRIAL APPLICATION FOR INVESTIGATIONAL FIRST-IN-CLASS NEW DRUG ALMB-0166 IN AUSTRALIA (in PDF)
  • 2019-August-7
  • DATE OF BOARD MEETING (in PDF)
  • 2019-July-29
  • VOLUNTARY ANNOUNCEMENT - NEW TARGET ANTI-TUMOR DRUG "SYHA1807" WAS GRANTED CLINICAL TRIAL APPROVAL (in PDF)
  • 2019-July-12
  • INSIDE INFORMATION - ANNOUNCEMENT ON THE INDICATIVE RESULTS FOR THE HALF YEAR ENDED 30 JUNE 2019 OF CSPC INNOVATION PHARMACEUTICAL CO., LTD.* (in PDF)
  • 2019-July-12
  • CONTINUING CONNECTED TRANSACTIONS - RENEWAL OF STEAM SUPPLY AGREEMENT (in PDF)
  • 2019-July-2
  • CHANGE OF ADDRESS OF SHARE REGISTRAR AND TRANSFER OFFICE (in PDF)
  • 2019-June-25
  • CONNECTED TRANSACTIONS - LEASE AGREEMENTS (in PDF)
  • 2019-June-13
  • VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "TICAGRELOR TABLETS" (in PDF)
  • 2019-June-10
  • VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "CLOPIDOGREL BISULFATE TABLETS" (in PDF)
  • 2019-May-27
  • POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 27 MAY 2019 (in PDF)
  • 2019-May-21
  • LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (in PDF)
  • 2019-May-21
  • CHANGE OF VICE-CHAIRMAN AND ROTATING CHIEF EXECUTIVE OFFICER (in PDF)
  • 2019-May-21
  • QUARTERLY RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2019 (in PDF)
  • 2019-May-8
  • DATE OF BOARD MEETING (in PDF)
  • 2019-May-7
  • VOLUNTARY ANNOUNCEMENT - FORMATION OF JOINT VENTURE (in PDF)
  • 2019-April-28
  • INSIDE INFORMATION - PRINCIPAL ACCOUNTING DATA AND FINANCIAL INDICATORS OF CSPC INNOVATION PHARMACEUTICAL CO., LTD .* FOR THE THREE MONTHS ENDED 31 MARCH 2019 (in PDF)
  • 2019-April-25
  • VOLUNTARY ANNOUNCEMENT - "PACLITAXEL CATIONIC LIPOSOME FOR INJECTION" FOR THE TREATMENT OF BREAST CANCER WAS GRANTED CLINICAL TRIAL APPROVAL (in PDF)
  • 2019-April-25
  • VOLUNTARY ANNOUNCEMENT - NEW ORAL ANTI-COAGULANT DRUG "SYHA136" WAS GRANTED CLINICAL TRIAL APPROVAL (in PDF)
  • 2019-April-17
  • NOTICE OF ANNUAL GENERAL MEETING (in PDF)
  • 2019-April-12
  • VOLUNTARY ANNOUNCEMENT - "SYHA1803" FOR THE TREATMENT OF INTRAHEPATIC CHOLANGIOCARCINOMA AND UROTHELIAL CARCINOMA WAS GRANTED CLINICAL TRIAL APPROVAL (in PDF)
  • 2019-April-12
  • VOLUNTARY ANNOUNCEMENT - "SYHA1402" FOR THE TREATMENT OF DIABETIC NEUROPATHY WAS GRANTED CLINICAL TRIAL APPROVAL (in PDF)
  • 2019-March-21
  • UPDATES ON THE SPIN-OFF AND SEPARATE LISTING OF CSPC XNW GROUP ON THE CHINEXT OF SHENZHEN STOCK EXCHANGE (in PDF)
  • 2019-March-18
  • ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2018 (in PDF)
  • 2019-March-6
  • DATE OF BOARD MEETING (in PDF)
  • 2019-March-5
  • VOLUNTARY ANNOUNCEMENT - SUBMISSION OF NDA TO U.S. FDA FOR LEVOAMLODIPINE MALEATE TABLETS (in PDF)
  • 2019-March-5
  • PROGRESS UPDATE ON THE PROPOSED SPIN-OFF AND SEPARATE LISTING OF CSPC XNW GROUP ON THE SHENZHEN STOCK EXCHANGE (in PDF)
  • 2019-March-3
  • PROGRESS UPDATE ON THE PROPOSED SPIN-OFF AND SEPARATE LISTING OF CSPC XNW GROUP ON THE SHENZHEN STOCK EXCHANGE (in PDF)
  • 2019-February-26
  • VOLUNTARY ANNOUNCEMENT - PRODUCT CO-DEVELOPMENT AND COMMERCIALIZATION AGREEMENTS (in PDF)
  • 2019-January-15
  • GRANT OF SHARES PURSUANT TO THE SHARE AWARD SCHEME OF THE COMPANY (in PDF)
  • 2019-January-10
  • UNUSUAL PRICE AND TRADING VOLUME MOVEMENT (in PDF)
  • 2019-January-7
  • VOLUNTARY ANNOUNCEMENT - ACQUISITION OF 100% INTEREST IN YONG SHUN TECHNOLOGY DEVELOPMENT LIMITED (in PDF)
  • 2019-January-4
  • VOLUNTARY ANNOUNCEMENT - PRODUCT CO-DEVELOPMENT AND STRATEGIC COLLABORATION AGREEMENT (in PDF)
  • 2022
  • 2022 Announcements & Notices
  • 2021
  • 2021 Announcements & Notices
  • 2020
  • 2020 Announcements & Notices
  • 2018
  • 2018 Announcements & Notices
  • 2017
  • 2017 Announcements & Notices
  • 2016
  • 2016 Announcements & Notices
  • 2015
  • 2015 Announcements & Notices
  • 2014
  • 2014 Announcements & Notices
  • 2013
  • 2013 Announcements & Notices
  • 2012
  • 2012 Announcements & Notices
  • 2011
  • 2011 Announcements & Notices
  • 2010
  • 2010 Announcements & Notices
  • 2009
  • 2009 Announcements & Notices
  • 2008
  • 2008 Announcements & Notices
  • 2007
  • 2007 Announcements & Notices
  • 2006
  • 2006 Announcements & Notices


  • Company's Index
  • irasia.com

  • About irasia.com   |   Terms of Use   |   Disclaimer
    © Copyright 1996-2022 irasia.com Ltd. All rights reserved.
    DISCLAIMER:
    irasia.com Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd. be liable for damages resulting from the use of the information provided on this website.